NEUROPILOT VR

Anxiety management VR therapy. Neuropilot is a cutting-edge medical device in the digital mental health industry, that revolutionizes anxiety treatment through real-time advanced brain modulation within immersive therapy. Utilizing next-generation The Desire Therapy (TDT), Neuropilot offers pre-designed, evidence-based, unique brain animation scenarios in VR, allowing users to explore intricate brain structures in VR. This method achieves unparalleled treatment effectiveness, addressing anxiety without triggering past traumas or fears, with precision and efficiency. In 5-minute sessions under minimal supervision, individuals can target anxiety by modifying brain wave activity. Neuropilot VR represents a paradigm shift in psychotherapy, revolutionizing clinical approaches to anxiety treatment, improving patient outcomes, and driving scientific innovation. The app is based on the unique TDT method, developed by psychologist/psychotherapist Maia Tskitishvili, which uses visualization techniques, neurophysiology, and quantum mind to manage excessive anxiety. Over 1500 sessions have empirically confirmed the therapy over five years, and experimental qEEG studies have exceeded expectations. Neuropilot is a product of a partnership between Maia Tskitishvili and VRex Immersive, designed to test initially on the local market, with plans to scale to Europe, Asia and the US. Studies show The Desire Therapy method increases concentration levels, enhances learning abilities, and helps strengthen the alpha rhythm, associated with calmness. Scalable technology such as VR, with built-in AI, makes it easier to distribute such applications globally, providing benefits to anyone who requires anxiety management.